- Home
- FOXA vs INSM Comparison
FOXA vs INSM Comparison
Compare FOXA & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXA
- INSM
- Stock Information
- Founded
- FOXA 2018
- INSM 1988
- Country
- FOXA United States
- INSM United States
- Employees
- FOXA N/A
- INSM N/A
- Industry
- FOXA Broadcasting
- INSM Biotechnology: Pharmaceutical Preparations
- Sector
- FOXA Industrials
- INSM Health Care
- Exchange
- FOXA Nasdaq
- INSM Nasdaq
- Market Cap
- FOXA 26.6B
- INSM 29.0B
- IPO Year
- FOXA N/A
- INSM 2000
- Fundamental
- Price
- FOXA $59.65
- INSM $159.46
- Analyst Decision
- FOXA Buy
- INSM Strong Buy
- Analyst Count
- FOXA 16
- INSM 19
- Target Price
- FOXA $57.00
- INSM $155.88
- AVG Volume (30 Days)
- FOXA 2.8M
- INSM 1.9M
- Earning Date
- FOXA 10-30-2025
- INSM 10-30-2025
- Dividend Yield
- FOXA 0.94%
- INSM N/A
- EPS Growth
- FOXA 56.87
- INSM N/A
- EPS
- FOXA 4.91
- INSM N/A
- Revenue
- FOXA $16,300,000,000.00
- INSM $398,105,000.00
- Revenue This Year
- FOXA N/A
- INSM $32.08
- Revenue Next Year
- FOXA $4.22
- INSM $125.86
- P/E Ratio
- FOXA $12.09
- INSM N/A
- Revenue Growth
- FOXA 16.59
- INSM 21.15
- 52 Week Low
- FOXA $41.59
- INSM $60.40
- 52 Week High
- FOXA $65.30
- INSM $168.22
- Technical
- Relative Strength Index (RSI)
- FOXA 52.03
- INSM 57.84
- Support Level
- FOXA $56.41
- INSM $154.79
- Resistance Level
- FOXA $59.45
- INSM $168.22
- Average True Range (ATR)
- FOXA 1.21
- INSM 4.28
- MACD
- FOXA -0.03
- INSM -1.32
- Stochastic Oscillator
- FOXA 55.38
- INSM 34.79
About FOXA Fox Corporation
Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay TV bundle. The Murdoch family controls Fox.
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.